The global Psoriasis Biologics Drugs market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Psoriasis Biologics Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Psoriasis Biologics Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Psoriasis Biologics Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Psoriasis Biologics Drugs include Amgen, UCB, Johnson & Johnson, Abbive, Innovent, Biocad, Novartis, Eli Lilly and Sun Pharmaceutical, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for Psoriasis Biologics Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Psoriasis Biologics Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Psoriasis Biologics Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Psoriasis Biologics Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Psoriasis Biologics Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Psoriasis Biologics Drugs sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Amgen, UCB, Johnson & Johnson, Abbive, Innovent, Biocad, Novartis, Eli Lilly and Sun Pharmaceutical, etc.
By Company
Amgen
UCB
Johnson & Johnson
Abbive
Innovent
Biocad
Novartis
Eli Lilly
Sun Pharmaceutical
Segment by Type
TNF-α Inhibitor
IL-12/23 Target Drug
IL-17 Target Drug
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Psoriasis Biologics Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Psoriasis Biologics Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Psoriasis Biologics Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Psoriasis Biologics Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Psoriasis Biologics Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 TNF-α Inhibitor
1.2.3 IL-12/23 Target Drug
1.2.4 IL-17 Target Drug
1.3 Market by Application
1.3.1 Global Psoriasis Biologics Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Psoriasis Biologics Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Psoriasis Biologics Drugs Revenue by Region
2.2.1 Global Psoriasis Biologics Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Psoriasis Biologics Drugs Revenue by Region (2018-2023)
2.2.3 Global Psoriasis Biologics Drugs Revenue by Region (2024-2029)
2.2.4 Global Psoriasis Biologics Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Psoriasis Biologics Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Psoriasis Biologics Drugs Sales by Region
2.4.1 Global Psoriasis Biologics Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Psoriasis Biologics Drugs Sales by Region (2018-2023)
2.4.3 Global Psoriasis Biologics Drugs Sales by Region (2024-2029)
2.4.4 Global Psoriasis Biologics Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Psoriasis Biologics Drugs Sales by Manufacturers
3.1.1 Global Psoriasis Biologics Drugs Sales by Manufacturers (2018-2023)
3.1.2 Global Psoriasis Biologics Drugs Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Psoriasis Biologics Drugs in 2022
3.2 Global Psoriasis Biologics Drugs Revenue by Manufacturers
3.2.1 Global Psoriasis Biologics Drugs Revenue by Manufacturers (2018-2023)
3.2.2 Global Psoriasis Biologics Drugs Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Psoriasis Biologics Drugs Revenue in 2022
3.3 Global Key Players of Psoriasis Biologics Drugs, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Psoriasis Biologics Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Psoriasis Biologics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Psoriasis Biologics Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Psoriasis Biologics Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Psoriasis Biologics Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Psoriasis Biologics Drugs Sales by Type
4.1.1 Global Psoriasis Biologics Drugs Historical Sales by Type (2018-2023)
4.1.2 Global Psoriasis Biologics Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Psoriasis Biologics Drugs Sales Market Share by Type (2018-2029)
4.2 Global Psoriasis Biologics Drugs Revenue by Type
4.2.1 Global Psoriasis Biologics Drugs Historical Revenue by Type (2018-2023)
4.2.2 Global Psoriasis Biologics Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Psoriasis Biologics Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Psoriasis Biologics Drugs Price by Type
4.3.1 Global Psoriasis Biologics Drugs Price by Type (2018-2023)
4.3.2 Global Psoriasis Biologics Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Psoriasis Biologics Drugs Sales by Application
5.1.1 Global Psoriasis Biologics Drugs Historical Sales by Application (2018-2023)
5.1.2 Global Psoriasis Biologics Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Psoriasis Biologics Drugs Sales Market Share by Application (2018-2029)
5.2 Global Psoriasis Biologics Drugs Revenue by Application
5.2.1 Global Psoriasis Biologics Drugs Historical Revenue by Application (2018-2023)
5.2.2 Global Psoriasis Biologics Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Psoriasis Biologics Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Psoriasis Biologics Drugs Price by Application
5.3.1 Global Psoriasis Biologics Drugs Price by Application (2018-2023)
5.3.2 Global Psoriasis Biologics Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Psoriasis Biologics Drugs Market Size by Type
6.1.1 US & Canada Psoriasis Biologics Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Psoriasis Biologics Drugs Revenue by Type (2018-2029)
6.2 US & Canada Psoriasis Biologics Drugs Market Size by Application
6.2.1 US & Canada Psoriasis Biologics Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Psoriasis Biologics Drugs Revenue by Application (2018-2029)
6.3 US & Canada Psoriasis Biologics Drugs Market Size by Country
6.3.1 US & Canada Psoriasis Biologics Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Psoriasis Biologics Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Psoriasis Biologics Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Psoriasis Biologics Drugs Market Size by Type
7.1.1 Europe Psoriasis Biologics Drugs Sales by Type (2018-2029)
7.1.2 Europe Psoriasis Biologics Drugs Revenue by Type (2018-2029)
7.2 Europe Psoriasis Biologics Drugs Market Size by Application
7.2.1 Europe Psoriasis Biologics Drugs Sales by Application (2018-2029)
7.2.2 Europe Psoriasis Biologics Drugs Revenue by Application (2018-2029)
7.3 Europe Psoriasis Biologics Drugs Market Size by Country
7.3.1 Europe Psoriasis Biologics Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Psoriasis Biologics Drugs Sales by Country (2018-2029)
7.3.3 Europe Psoriasis Biologics Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Psoriasis Biologics Drugs Market Size
8.1.1 China Psoriasis Biologics Drugs Sales (2018-2029)
8.1.2 China Psoriasis Biologics Drugs Revenue (2018-2029)
8.2 China Psoriasis Biologics Drugs Market Size by Application
8.2.1 China Psoriasis Biologics Drugs Sales by Application (2018-2029)
8.2.2 China Psoriasis Biologics Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Psoriasis Biologics Drugs Market Size by Type
9.1.1 Asia Psoriasis Biologics Drugs Sales by Type (2018-2029)
9.1.2 Asia Psoriasis Biologics Drugs Revenue by Type (2018-2029)
9.2 Asia Psoriasis Biologics Drugs Market Size by Application
9.2.1 Asia Psoriasis Biologics Drugs Sales by Application (2018-2029)
9.2.2 Asia Psoriasis Biologics Drugs Revenue by Application (2018-2029)
9.3 Asia Psoriasis Biologics Drugs Sales by Region
9.3.1 Asia Psoriasis Biologics Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Psoriasis Biologics Drugs Revenue by Region (2018-2029)
9.3.3 Asia Psoriasis Biologics Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Psoriasis Biologics Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Psoriasis Biologics Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Psoriasis Biologics Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Psoriasis Biologics Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Psoriasis Biologics Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Psoriasis Biologics Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Psoriasis Biologics Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Psoriasis Biologics Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Psoriasis Biologics Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Psoriasis Biologics Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Overview
11.1.3 Amgen Psoriasis Biologics Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Amgen Psoriasis Biologics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen Recent Developments
11.2 UCB
11.2.1 UCB Company Information
11.2.2 UCB Overview
11.2.3 UCB Psoriasis Biologics Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 UCB Psoriasis Biologics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 UCB Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Psoriasis Biologics Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Johnson & Johnson Psoriasis Biologics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 Abbive
11.4.1 Abbive Company Information
11.4.2 Abbive Overview
11.4.3 Abbive Psoriasis Biologics Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Abbive Psoriasis Biologics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abbive Recent Developments
11.5 Innovent
11.5.1 Innovent Company Information
11.5.2 Innovent Overview
11.5.3 Innovent Psoriasis Biologics Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Innovent Psoriasis Biologics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Innovent Recent Developments
11.6 Biocad
11.6.1 Biocad Company Information
11.6.2 Biocad Overview
11.6.3 Biocad Psoriasis Biologics Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Biocad Psoriasis Biologics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Biocad Recent Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Overview
11.7.3 Novartis Psoriasis Biologics Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Novartis Psoriasis Biologics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis Recent Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Information
11.8.2 Eli Lilly Overview
11.8.3 Eli Lilly Psoriasis Biologics Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Eli Lilly Psoriasis Biologics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Eli Lilly Recent Developments
11.9 Sun Pharmaceutical
11.9.1 Sun Pharmaceutical Company Information
11.9.2 Sun Pharmaceutical Overview
11.9.3 Sun Pharmaceutical Psoriasis Biologics Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Sun Pharmaceutical Psoriasis Biologics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sun Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Psoriasis Biologics Drugs Industry Chain Analysis
12.2 Psoriasis Biologics Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Psoriasis Biologics Drugs Production Mode & Process
12.4 Psoriasis Biologics Drugs Sales and Marketing
12.4.1 Psoriasis Biologics Drugs Sales Channels
12.4.2 Psoriasis Biologics Drugs Distributors
12.5 Psoriasis Biologics Drugs Customers
13 Market Dynamics
13.1 Psoriasis Biologics Drugs Industry Trends
13.2 Psoriasis Biologics Drugs Market Drivers
13.3 Psoriasis Biologics Drugs Market Challenges
13.4 Psoriasis Biologics Drugs Market Restraints
14 Key Findings in The Global Psoriasis Biologics Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Amgen
UCB
Johnson & Johnson
Abbive
Innovent
Biocad
Novartis
Eli Lilly
Sun Pharmaceutical
*If Applicable.